Principal Investigator Agreement for Investigational Device StudyPrincipal Investigator Agreement • August 18th, 2020
Contract Type FiledAugust 18th, 2020In accordance with Good Clinical Practice (GCP) and Food and Drug Administration (FDA) regulations, 21 CFR Part 812, Investigational Device Exemptions (IDE), and 21 CFR Part 50, Protection of Human Subjects, this document serves as an Investigator Agreement for: